Diabetes Foundation Aotearoa are proud to be a community based study site for the randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH).
Clinical Projects Manager/Researcher Kate Smallman and Research Assistant Trish Harry are delivering recruiting and management activities from our Otara office. Recruiting is expected to finish is 2020.
More information on what the study is about can be found in an article here and the study protocol is available here BMJ Open. 2020 Sep 1;10(9):e036518. doi: 10.1136/bmjopen-2019-03651
